Products

Assert-IQ (DM5100)
Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)
Cardiology AI
The Assert-IQ™ Insertable Cardiac Monitor (ICM) is a Bluetooth-enabled device from Abbott that provides continuous, real-time heart monitoring and arrhythmia detection, utilizing AI algorithms to reduce false positives and offer long-term diagnostic evaluation for patients with cardiac conditions.

See all 1 product →

About Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

Abbott’s Assert-IQ™ Insertable Cardiac Monitor (ICM) is a cutting-edge medical device that integrates advanced AI algorithms to enhance cardiac monitoring and patient management. This Bluetooth-enabled ICM is designed for long-term, reliable heart rhythm monitoring, offering options with battery lives of at least three or six years. The device is subcutaneously inserted in the left pectoral region and continuously checks heart rhythms, transmitting important findings in near real-time to a clinic’s portal, often via the patient’s own mobile phone. The Assert-IQ ICM is indicated for patients experiencing unexplained cardiac-related symptoms such as dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as those at risk for cardiac arrhythmias like bradycardia, tachycardia, and sinus pauses.

The core innovation of the Assert-IQ ICM lies in its AI algorithms, which significantly reduce false positives from Atrial Fibrillation (AF) and Pause episodes while maintaining high sensitivity. These cloud-based neural networks are trained on thousands of electrograms (EGMs) reviewed by electrophysiologists, allowing them to reliably classify episodes in a manner consistent with specialist interpretation. This intelligent filtering of data helps healthcare teams prioritize true AFib episodes, providing clearer insights faster and reducing the burden of managing excessive data. The system also offers remote programmability, enabling clinicians to adjust device settings without requiring in-person patient visits, further streamlining clinic workflow. The Assert-IQ ICM represents a significant advancement in connected health technologies, aiming to improve clinical efficiency and provide actionable data for tailored patient care plans.

Focus Areas

Medical devices (including cardiovascular and neuromodulation products diabetes care products) diagnostics (core lab molecular point of care rapid diagnostics) nutritional products (pediatric and adult nutrition) and established pharmaceuticals (branded generic medicines for sale outside the United States).

What Physicians Need to Know

Medical Devices (Assert-IQ ICM)
Abbott's Assert-IQu2122 Insertable Cardiac Monitor (ICM) is a slim, intelligent, and fast device designed for long-term monitoring and diagnostic evaluation of patients experiencing irregular heartbeats. It continuously checks heart rhythms and transmits real-time clinical data. The system features Key Episode technology, allowing clinicians to investigate all episodes or three key episodes, and offers remote programming for physicians to adjust settings and optimize performance. The Assert-IQ ICM also includes supplementary sensors that capture various diagnostics, such as a leading premature ventricular contraction (PVC) detection algorithm and body position and posture. It is the only ICM system to combine AI, the longest-lasting Bluetoothu00ae ICM, and IQ Insights to optimize patient management across arrhythmia types.
AI Agent (General AI Agent concept)
AI agents in healthcare are autonomous software systems that utilize artificial intelligence to perceive information, reason across data, and perform tasks that support clinical care, operations, and patient engagement with minimal human intervention. They are designed to operate with a degree of independence within defined boundaries. These agents can assist with clinical documentation, patient data intake, triage, diagnostics, and care coordination, improving provider efficiency and patient outcomes. AI agents can also power virtual assistants, chatbots, and other tools for appointment scheduling, intake, and basic patient communication.
Diagnostics
Abbott offers a broad range of innovative diagnostic instrument platforms, tests, and services across core lab, molecular, point-of-care, and rapid diagnostics. Their solutions aim to provide accurate, timely information for better health management and to drive operational efficiencies. Abbott is a global leader in rapid diagnostic tests for infectious diseases, cardiometabolic diseases, and toxicology, providing fast, reliable, and actionable information. The Alinity family of solutions is a next-generation line of instruments and informatics designed for greater efficiency and fast, accurate test results.
Nutritional Products
Abbott provides science-based nutritional products for all stages of life, from infancy to adulthood. Their portfolio includes well-known brands such as Similacu00ae infant formulas, Ensureu00ae nutrition shakes, PediaSureu00ae for pediatric nutrition, and Pedialyteu00ae for hydration. They also offer specialized nutrition products like Glucernau00ae for diabetes, Juvenu00ae for wound healing, and Neprou00ae for kidney disease requiring dialysis.
Established Pharmaceuticals
Abbott's Established Pharmaceuticals Division (EPD) focuses on providing high-quality, trusted branded generic medicines for sale outside the United States, particularly in emerging markets. Their strategy involves increasing access to existing products through geographic expansion, improving therapeutic benefits through innovation in formulation and delivery, and expanding local product portfolios. They differentiate themselves through high quality standards, a reliable supply chain, clinical science, and innovation beyond the molecule, such as new delivery methods or digital solutions to improve patient adherence.
Physician Tip

For physicians, Abbott's Assert-IQ ICM offers advanced AI algorithms that significantly reduce false positives for AF and pause events, allowing for more focused review of clinically relevant information. The device's long battery life (up to six years) provides flexibility for long-term monitoring. Remote programming capabilities streamline clinic workflow by allowing adjustments without in-person patient visits. For diagnostics, Abbott's rapid and point-of-care tests provide quick, actionable results to inform timely treatment decisions. The AI Agent concept, when integrated, can automate administrative tasks like clinical documentation, patient data intake, and care coordination, freeing up physician time for patient care. In nutrition, Abbott's science-based products offer a wide range of options to support patients across various life stages and specific disease states. For established pharmaceuticals, the focus on high-quality, affordable branded generics in emerging markets provides trusted treatment options for a broad patient population.

Abbott's Assert-IQ ICM leverages Bluetoothu00ae-enabled technology for automatic and seamless transmission of patient information to the myMerlinu2122 Mobile App and Merlin.netu2122 Patient Care Network portal. The system's AI algorithms work in the cloud, requiring no in-person clinical adjustments to the device. Abbott is also integrating IoT technology into its medical devices for remote monitoring, with a focus on cybersecurity. For their global healthcare SaaS platform for diabetes management, Abbott utilizes full-stack development with technologies like Go, React, Node.js, JavaScript, HTML, CSS, JSX, RESTful APIs, microservices, SQL Server, PostgreSQL, MySQL, Git, Bitbucket, Jira, Confluence, Docker, Kubernetes, Grafana, Segment, Sentry, Mixpanel, and Linux environments. AI agents in healthcare are designed to integrate with enterprise systems and clinical tools, including mobile apps and EHRs, to improve operational efficiency and manage care pathways across multiple teams and systems.

Products by Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

1 product in the directory

Assert-IQ (DM5100)
Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)
Cardiology AI
The Assert-IQ™ Insertable Cardiac Monitor (ICM) is a Bluetooth-enabled device from Abbott that provides continuous, real-time heart monitoring and arrhythmia detection, utilizing AI algorithms to reduce false positives and offer long-term diagnostic evaluation for patients with cardiac conditions.

Videos

News, demos, and interviews about Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept).

Loading videos...

Videos load interactively. If none appear, search YouTube for Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Abbott's Assert-IQ ICM is designed with interoperability in mind, utilizing standard communication protocols to facilitate seamless integration with various hospital systems and EHR platforms. This allows for efficient data exchange and streamlined workflows for healthcare providers. Specific integration details and capabilities can be discussed with an Abbott representative to ensure compatibility with your institution's infrastructure.
Abbott's Assert-IQ ICM and other AI-powered diagnostic tools adhere to rigorous regulatory standards set by bodies such as the FDA and EMA. Compliance extends to data privacy (e.g., HIPAA, GDPR), cybersecurity, and the ethical use of AI in healthcare. Abbott provides comprehensive documentation and support to help institutions navigate these compliance requirements and ensure safe and effective implementation.
Abbott offers flexible pricing structures and support models tailored to the needs of large healthcare networks, encompassing their medical devices, diagnostics, and nutritional products. These can include volume-based discounts, bundled solutions, and tiered service agreements. Dedicated account managers and technical support teams are available to provide comprehensive assistance, training, and ongoing maintenance.
Abbott actively pursues strategic partnerships with academic institutions, technology companies, and other healthcare innovators to advance its AI capabilities and broaden the impact of its solutions. These collaborations focus on research and development, co-creation of new technologies, and expanding market access for Abbott's diverse portfolio of medical devices, diagnostics, and nutritional products.
Abbott maintains a strong commitment to research and development, investing significantly in continuous innovation across its product lines, including AI-driven diagnostics and neuromodulation. The company's financial stability, diverse portfolio, and global presence ensure long-term viability and the ability to adapt to evolving healthcare needs and technological advancements. Regular product updates and new releases are part of Abbott's strategy to remain at the forefront of medical innovation.
Abbott offers extensive training and educational resources for physicians and healthcare staff to ensure the effective and safe use of their diabetes care products and diagnostic platforms. This includes on-site training, online modules, webinars, and access to clinical specialists. These resources are designed to optimize product utilization, enhance patient outcomes, and support ongoing professional development.
Abbott prioritizes data security and patient privacy across all its connected medical devices and diagnostic solutions. The company employs robust encryption, access controls, and adherence to global data protection regulations like HIPAA and GDPR. Regular security audits and updates are conducted to safeguard sensitive patient information and maintain the highest standards of data integrity.

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

MediSync AI is a healthcare AI company focused on transforming patient care and boosting revenue through AI-driven solutions, particularly in Remote Patient Monitoring (RPM). Their platform extends healthcare beyond traditional boundaries, offering continuous care to patients wherever they are. They aim to enhance patient experience and outcomes while providing tools for clinicians and revenue optimization […]

Snore Screen offers an AI-powered craniofacial screening tool designed to identify the risk of obstructive sleep apnea (OSA) in under 60 seconds using a single facial scan. This non-invasive optical phenotyping technology helps physicians prioritize clinical referrals, reduce sleep lab backlogs, and streamline patient triage. The platform analyzes craniofacial markers, such as mandibular structure, neck […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.